’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy​

’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy​

RSS » New York Times News » NYTHealth

’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy​

January 13, 2026

00HS-psilocybin-01-vpmf-mediumSquareAt3X-Xog0VU-rss

 Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • Outbreaks and Emerging Issues
Pandemic Preparedness and Resilience After COVID-19
Pandemic Preparedness and Resilience
  • Events and Conferences
Major One Health Conferences to Attend in April 2026
One Health Conferences April 2026
  • Public Awareness and Engagement
Global Obesity Prevention in a Changing World
Global Obesity Prevention

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts